July 25, 2024 - July 29, 2024

Clinitech Laboratory IPO Review & Recommendations

Clinitech Laboratory IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated

Clinitech Laboratory IPO Peer Comparison

Clinitech Laboratory Limited peer comparison with similar listed entities. (As on March 31, 2024)

Company Name	EPS (Basic)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio	Financial statements
Clinitech Laboratory Limited	2.37	21.12	43.45	10.46	4.55
Dr Lalpath Labs	43.05	225.85	67.92	19.19	12.03	Consolidated
Thyrocare Technologies Ltd	13.42	99.65	47.56	13.17	6.41	Consolidated
Krsnaa Diagnostics Limited	17.90	250.79	38.42	7.02	2.74	Consolidated

Notes:

Closing Market Price: Issue Price for Clinitech and closing market price on July 09, 2024, on BSE for Others.
The P/E Ratio is computed by dividing the Issue Price/closing market price on July 09, 2024, on BSE by EPS.
Data for peer Companies are sourced from the Annual Report based on Consolidated financials for FY2024/FY 2023 / FY 2022.
RONW / EPS / NAV etc. is adjusted for face value.
Clinitech financials are based on March 31, 2024, Restated Financials.

Clinitech Laboratory IPO Review by Members

Clinitech Laboratory IPO Reviews, analysis and views by popular members. Read Clinitech Laboratory Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Clinitech Laboratory IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%

Member	Review
No recommendation found. Be the first to post the recommendation.

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Comments

Add a public comment...